جست‌وجوی استاد و پژوهشگر

• Antimicrobial Agents
• Antibiotic Drug Discovery
• Infectious Diseases
• +۳ مورد دیگر

Soumya Ramu is a researcher affiliated with the University of Queensland's Frazer Institute, focusing on antimicrobial drug discovery and antibiotic development. Her work spans antibacterial, antifungal, and antiparasitic compounds with an emphasis on overcoming antibiotic resistance mechanisms. Research Interests: Ms. Ramu's research includes developing novel antibiotics against drug-resistant bacteria, evaluating existing drugs for repurposing (e.g., cannabidiol), and studying chemical agents targeting biofilm-associated infections. She explores metal-ion complexation effects on antibiotic activity and investigates mechanisms of bacterial resistance. Collaborations: Her work involves interdisciplinary teams across medicinal chemistry, microbiology, and pharmacology, collaborating with institutions like the Translational Research Institute and global researchers in antibiotic development. Publications: Ramu's 24+ journal articles and conference papers (2012-2022) highlight contributions to antibiotic design, resistance mechanisms, and drug-activity optimization. Key topics include lipoglycopeptides for biofilm infections, platinum-based antibacterial complexes, and minor groove binder therapeutics.

Xiu-Min Liمشاهده پروفایل

استاد

• Traditional Chinese Medicine
• Allergies
• Immunology
• +۳ مورد دیگر

Xiu-Min Li is a Professor in the School of Medicine at New York Medical College , specializing in Pathology, Microbiology, and Immunology . She holds dual expertise in Traditional Chinese Medicine (TCM) and Western medicine , with a focus on integrative approaches to treating skin, respiratory, and digestive system disorders resistant to conventional therapies. Education: M.D., Henan University of Chinese Medicine Postdoctoral Fellowship in Clinical Immunology, Johns Hopkins University Her research integrates TCM principles with modern nano-medicine to isolate active botanical components for allergy and inflammation, enabling reproducible clinical applications. She has pioneered patents and co-founded a biotech startup to bridge lab-based natural products to real-world interventions. Recent publications highlight her work on TCM for pediatric allergies , cannabinoid derivatives in cancer , biomarkers in dermatitis , and microbiome-obesity links . A founder of the East-West Integrative Medicinal Symposia , she connects global experts in immunology and wellness technology. Key research themes include TCM molecular dissection , bioavailability challenges , immune system mechanisms , and microbiome-allergy interactions .

Kelly Riceمشاهده پروفایل

دانشیار

• Microbiology
• Bacterial Pathogenesis
• Space Biology
• +۴ مورد دیگر

Dr. Kelly Rice is an Associate Professor in the Department of Microbiology & Cell Science at the University of Florida. Her research focuses on bacterial physiology, particularly under extreme conditions such as microgravity, and mechanisms of bacterial pathogenesis, including biofilm formation, quorum sensing, and virulence factor regulation. She investigates how environmental stressors influence microbial behavior, with a focus on species like Streptococcus mutans and Staphylococcus aureus . Her work includes studies on the molecular mechanisms of programmed cell death in bacteria, the impact of spaceflight on bacterial metabolism, and the development of antibacterial materials using lignin derivatives. Dr. Rice’s research also explores the transmission of oral bacteria to fetal tissues during late gestation, highlighting the intersection of microbiology and clinical applications. Publications span topics such as the Cid/Lrg system’s role in Streptococcus mutans metabolism, microgravity-induced proteomic changes in pathogens, and the use of confocal microscopy to analyze biofilm structures. Her contributions advance understanding of bacterial adaptation to environmental stress and translational applications in antimicrobial strategies.

Scott A Guelcherمشاهده پروفایل

استاد

• Bone Tissue Engineering
• Polymeric Biomaterials
• Orthopedic Biomaterials
• +۳ مورد دیگر

Scott A. Guelcher is a Professor of Chemical and Biomolecular Engineering, Biomedical Engineering, and Pathology, Microbiology and Immunology at Vanderbilt University's School of Engineering. His research focuses on developing polymeric biomaterials for bone tissue engineering, including injectable scaffolds, biodegradable composites, and drug delivery systems. His work addresses clinical needs in orthopedics, such as bone graft alternatives and fracture fixation devices. Education: PhD in Chemical Engineering from Carnegie Mellon University (Carnegie Mellon), M.S. from University of Pittsburgh, and B.S. from Virginia Tech. Research interests include designing biomaterials with tunable mechanical/biological properties, ex vivo bone tissue engineering in perfusion bioreactors, and ROS-degradable materials for wound healing. Collaborations include Virginia Tech and allograft bone companies. Industrial experience includes Eastman Chemical Company and Bayer Corporation's Polyurethanes Division. Key contributions include injectable polyurethane foams for bone repair, biodegradable fracture fixation devices, and 3D-printed bone models for tumor-bone disease studies. His work integrates materials science, biomedical engineering, and clinical applications to advance regenerative medicine.

Julia Steinhoff-Wagnerمشاهده پروفایل

استاد

• Animal Nutrition
• Metabolism
• Sustainable Agriculture
• +۳ مورد دیگر

Prof. Julia Steinhoff-Wagner is a Professor of Animal Nutrition and Metabolism at the Technical University of Munich (Freising-Weihenstephan), affiliated with the TUM School of Life Sciences. She holds a Venia Legendi (Habilitation) in Nutritional Physiology and Health Management from the University of Bonn. Her research focuses on sustainable feed production, environmental risk assessment of veterinary products, and animal welfare in livestock systems. Education: She graduated from Christian-Albrechts-University Kiel with a BSc (2005), MSc (2007), and PhD (2010) in Agricultural Sciences. Postdoctoral training included roles at Baylor College of Medicine (USA) and the Leibniz Institute for Farm Animal Biology (Germany). BSc (2005): Animal Science MSc (2007): Animal Science PhD (2010): Farm Animal Physiology Habilitation (2019): Nutritional Physiology and Health Management Research interests include: - Circular economy in animal production - Stewardship of resources across the food chain - Nutritional strategies for optimal animal health - Mitigation of environmental contaminants in livestock systems Key awards: - Fellowship for Digital Teaching Innovation (NRW Ministry, €49,852, 2019) - Teaching Prize for Digital Innovation (University of Bonn, €30,000, 2018) Advising/grants: Over €1 million in project acquisitions. Active in training programs for farmers focusing on hygiene and resource management.

• Molecular Microbiology
• Immunology
• Bacterial Pathogenesis
• +۱۳ مورد دیگر

Stefan Bagby is a Reader in the Department of Life Sciences at the University of Bath, affiliated with the Centre for Nanoscience and Nanotechnology and the Centre for Bioengineering & Biomedical Technologies (CBio). He is an active faculty member with a strong research profile in molecular microbiology, immunology, and biophysical biochemistry. His work integrates genomics, structural biology, and nanotechnology to study bacterial pathogenesis and host immune responses. His research focuses on Staphylococcus aureus and Bordetella pertussis , exploring mechanisms of immune evasion, protein-protein interactions, and post-translational modifications such as lipoylation and palmitoylation. He also investigates cancer immunology, autoantibodies in myositis, and the application of nanopore sequencing and graphene-based biosensors for diagnostics and biotechnological applications. The recent publications highlight a strong trend in nanopore-based metagenomics for respiratory infection diagnostics, pan-cancer immune gene signatures , and bacterial genomics for understanding pathogen evolution. His work bridges fundamental molecular mechanisms with translational applications in infection, autoimmunity, and cancer. Scientific Contributions: Extensive research on Staphylococcus aureus immune evasion proteins (Efb, Sbi). Pioneering use of nanopore sequencing in bacterial genomics and clinical metagenomics. Development of graphene-based biosensing platforms using supramolecular enzyme complexes. Investigations into autoantibodies in myositis and their clinical implications. Supervision and Collaboration: He is actively accepting doctoral students and has supervised at least 10 research projects. His interdisciplinary work involves collaborations across biochemistry, immunology, oncology, and nanotechnology. Laboratory and Facilities: His research is supported by the Centre for Nanoscience and Nanotechnology and CBio, providing access to advanced instrumentation for protein biophysics, genomics, and nanomaterial-based sensing.

• Immunology
• Infectious Diseases
• Host-Pathogen Interactions
• +۳ مورد دیگر

Kelly Shepardson is an Assistant Professor in the Department of Molecular Cell Biology within the School of Natural Sciences at the University of California, Merced. Her laboratory is located in BSP 462, with her office in BSP 463. She can be contacted at kshepardson2@ucmerced.edu. Her research focuses on immunology and infectious diseases , particularly host-pathogen interactions involving viral, bacterial, and fungal pathogens. Key areas include: Immune mechanisms in pulmonary infections Viral-bacterial-fungal coinfections Macrophage biology and innate immune signaling Pathogen recognition receptors (TLRs, NLRs) Cytokine regulation in infection outcomes Her publication record (2015-2025) demonstrates consistent focus on: Influenza pathogenesis and superinfections Aspergillus and other fungal infections SARS-CoV-2 coinfection models Mouse models of respiratory infections Molecular mechanisms of immune regulation

• Infectious Diseases
• Microbiology
• Immunology
• +۲ مورد دیگر

Allon Edward Moses serves as a Visiting Professor in the Department of Microbiology and Immunology at the School of Medicine, European University Cyprus, while maintaining active clinical leadership as Senior Physician at Hadassah-Hebrew University Medical Center in Jerusalem since 1991, including tenure as Head of Department (2005-2020). His academic credentials include: MD, Ben Gurion University of the Negev, Israel (1981) Residency in Medicine, Hadassah Hebrew University Medical Center (1988) Infectious Diseases Fellowship, Harvard Medical School (1991) Dr. Moses' research centers on infectious disease pathogenesis with emphasis on microbiome dynamics, antibiotic resistance mechanisms, and streptococcal infections. His work bridges clinical practice and translational research, addressing critical challenges in infection control and novel therapeutic interventions for resistant pathogens through hospital-based epidemiological studies. His publication trajectory (2013-2022) reveals evolving expertise from bacterial genetics (sil characterization, 2013) to contemporary pandemic responses (COVID-19 vaccine efficacy, 2022), with consistent focus on microbiome applications (vaginal transplantation, 2019) and alternative antimicrobial strategies (bacteriophage therapy, 2019). These studies demonstrate methodological diversity across cohort analyses, cross-sectional behavioral research, and therapeutic case reports. No major scientific awards are documented in the provided information. Research funding includes the human microbiome of the external ear canal project (2021-2022), and the politically impacted antibiotic stewardship initiative in Palestinian hospitals (2023-2025) funded by USAID's Middle East Regional Cooperation Program (MERC), which was approved but withheld following US policy changes regarding Palestinian Authority funding. He also contributed to the government-sponsored project "Reduction of Hospital Acquired Infections in Israeli and Palestinian Hospitals". Dr. Moses maintains extensive clinical-research collaborations across Israeli medical centers, particularly Hadassah-Hebrew University teams, with documented partnerships spanning infectious disease epidemiology, microbiome therapeutics, and cross-border public health initiatives despite geopolitical constraints.

Ming Hammondمشاهده پروفایل

استاد

• Biosensors
• RNA
• Fluorescence Imaging
• +۴ مورد دیگر

Ming Hammond serves as Professor of Chemistry in the Department of Biological Chemistry at the University of Utah School of Medicine, where she leads innovative research in RNA-based molecular imaging and cyclic dinucleotide signaling pathways. Her work bridges chemical biology and microbiology to develop programmable biosensors and decode bacterial immune communication mechanisms. Education: B.S. from California Institute of Technology Ph.D. from University of California, Berkeley Dr. Hammond's research centers on engineering nucleic acids as tools for live-cell imaging and gene control , with dual emphases on (1) RNA-fluorophore biosensors for visualizing enzyme activity in bacteria under diverse conditions, and (2) cyclic dinucleotide signaling in bacterial/mammalian systems. Her lab pioneered riboswitch-based biosensors with sub-nanomolar sensitivity and demonstrated zinc-mediated regulation of biofilm formation in E. coli . Recent work explores bacterial cGAMP signaling via Hypr GGDEF enzymes and mammalian immune responses involving cGAS-cGAMP-STING pathways. Analysis of her 15 most recent publications reveals a decisive shift toward advanced biosensor engineering (bioluminescent, ratiometric) and mechanistic dissection of cyclic dinucleotide networks across bacterial species. Key trends include expanding applications to spaceflight environments, atomic-level tuning of immune responses, and cross-species comparisons of second-messenger systems. Awards: Signaling Breakthrough of the Year (Science Signaling, 2015) Dr. Hammond mentors graduate students in the Biological Chemistry PhD program and directs an active research laboratory. Her work is supported by NIH and NSF grants focused on nucleic acid engineering and host-pathogen signaling, though specific awards are not detailed in the source text. Collaborative projects include structural studies with UC Berkeley's Russell Vance on cGAMP immune signaling. The Hammond Lab operates at the chemistry-biology interface, utilizing fluorescence microscopy, flow cytometry, and synthetic biology to investigate signaling dynamics in single cells. Current efforts emphasize translating biosensor technologies to study bacterial communication in complex environments and immune evasion mechanisms.

Rebecca Owensمشاهده پروفایل

استادیار

• Proteomics
• Microbial Pathogenesis
• Antimicrobial Resistance Mechanisms
• +۳ مورد دیگر

Dr. Rebecca Owens is an Assistant Professor in the Department of Biology at Maynooth University, affiliated with the Human Health Institute. She holds a BSc (Biotechnology) from Maynooth University (2008) and a PhD (2013), supported by an IRCSET Scholarship. Her postdoctoral research focused on fungal pathogen proteomics, particularly iron-limiting conditions and mass spectrometry methodologies. In 2017, she established the Chemical Microbiology laboratory, specializing in proteomic analyses of microbial species and antimicrobial resistance mechanisms. Her work bridges academia and industry, expanding into food technology and microbiology. Dr. Owens currently supervises 4 PhD students funded by DAFM and Teagasc. Her research interests include: proteomic responses to antifungals, fungal pathogen virulence, and mass spectrometry-based methods for analyzing microbial metabolites. She has contributed to over 40 peer-reviewed publications and book chapters, including seminal work on fungal proteomics and gliotoxin biology. Dr. Owens serves on professional committees, including Treasurer of the Irish Fungal Society and Member of the Microbiology Society’s Irish Division. Her lab’s recent work explores zinc chelation by gliotoxin, HMO-primed bifidobacteria, and bovine colostrum proteomics.

• Food Chemistry
• Antimicrobial Agents
• Phytochemicals
• +۴ مورد دیگر

Carla Araya Cloutier is an Assistant Professor in Food Chemistry at Wageningen University & Research . Her research focuses on antimicrobial phytochemicals , particularly prenylated isoflavonoids and chalcones from plants like licorice and legumes. She explores their mechanisms of action against pathogens such as Listeria monocytogenes , Streptococcus mutans , and Staphylococcus aureus , aiming to combat antimicrobial resistance and improve food safety. Her work includes studies on efflux pump inhibition, membrane permeabilization, and cytotoxicity. She has received the Veni Award 2019 from NWO for her project on plant-based efflux pump inhibitors. She co-supervises multiple PhD projects, including work on natural antimicrobial valorization and phytochemical mechanisms. Key collaborations involve institutions like the University of Nottingham for datasets on transcriptomic responses to antimicrobial compounds. Her research spans food safety, natural product chemistry, and microbiology , with applications in developing sustainable antimicrobial solutions. She has published extensively on prenylated phenolics, isothiocyanates, and their roles in bacterial defense systems.

Ana C. Vallorمشاهده پروفایل

دانشیار

• Medical Microbiology
• Antimicrobial Drug Discovery
• Probiotics and Microbial Ecology
• +۴ مورد دیگر

Dr. Ana C. Vallor is an Associate Professor of Biology at the University of the Incarnate Word (UIW), tenured since 2014. She holds a Ph.D. in Molecular Virology and Microbiology from the University of Pittsburgh (2002) and a B.S. in Biology from St. Mary’s University (1990). Her research focuses on antimicrobial discovery, probiotic applications, and microbial transmission dynamics, with recent work emphasizing drug biotransformation and soil-derived antimicrobial compounds. Dr. Vallor has authored/co-authored over 30 peer-reviewed publications and actively mentors undergraduate and graduate students in laboratory research. Academic leadership roles include Director of the Masters of Biology Program (2016–2018), Microbiology Course Coordinator, and service on institutional review boards. She is a member of SACNAS, ASM, and the San Antonio Center for Medical Mycology. Notable awards include the Presidential Teaching Legacy Award (2015) and the Sr. Joseph Marie Armer CCVI Endowed Chair (2019–2021). Her research explores novel antimicrobial agents from South Texas soil microorganisms, probiotic Lactobacillus species’ roles in pathogen inhibition, and fungal drug metabolism. Recent projects include HPLC analysis of antifungal biotransformation products and assessment of essential oils’ antibacterial efficacy. Dr. Vallor also leads educational outreach initiatives through programs like Tiny Earth and Upward Bound.

Karen Kotloffمشاهده پروفایل

استاد

• Infectious Disease Epidemiology
• Vaccine Development
• Clinical Trials
• +۸ مورد دیگر

Karen Kotloff, MD, is a Professor in the Department of Pediatrics at the University of Maryland School of Medicine. She serves as Head of the Division of Infectious Disease and Tropical Pediatrics and Associate Director of Clinical Studies at the Center for Vaccine Development and Global Health (CVD). Her work spans clinical practice, research leadership, and international public health initiatives. Education: BA in Psychology (Washington University, 1975), MD (Temple University School of Medicine, 1979) Secondary Appointments: Medicine, Epidemiology & Public Health Dr. Kotloff specializes in pediatric infectious diseases and vaccine development. Her research focuses on global child mortality reduction through clinical trials and epidemiological studies, particularly in developing countries. Key projects include the GEMS, VIDA, CHAMPS, and SANTE studies, addressing diarrheal diseases, pneumonia, and maternal-infant mortality prevention. Her scientific contributions have earned international recognition, including the Knight of the National Order of Mali (2005), Temple University Alumni Achievement Award (2019), and Founders' Day Research of the Year (2018). She leads multiple NIH- and Gates Foundation-funded initiatives, including Phase 3 COVID-19 vaccine trials and azithromycin distribution programs. Selected Awards Chevalier de l’Ordre National du Mali (2005) Distinguished Professor (2021) Temple University Alumni Achievement Award (2019) Founders' Day Research of the Year (2018) Baltimore Magazine’s Best Doctors (2013-2014) Alexander I. Shaeffer Teaching Award (1987-1988) Dr. Kotloff participates in international advisory committees for the Bill & Melinda Gates Foundation and the World Health Organization, advancing vaccine implementation strategies in Africa and Asia.

Kangmin Duanمشاهده پروفایل

استاد

• Bacterial pathogenicity
• Antimicrobial drug resistance
• Host-microbe interactions
• +۶ مورد دیگر

Kangmin Duan, PhD, is a Professor at the Dr. Gerald Niznick College of Dentistry and cross-appointed to the Department of Medical Microbiology and Infectious Diseases at Max Rady College of Medicine, University of Manitoba. He serves as a scientist at the Children's Hospital Research Institute of Manitoba (CHRIM) and a principal investigator in the Manitoba Chemosensory Biology Research Group (MCSB). Education: Postdoctoral Fellowship, University of Calgary Doctor of Philosophy, University of New South Wales Master of Applied Science, University of New South Wales Master of Science, Northwest University (China) Doctor of Philosophy, Northwest University (China) Dr. Duan's research program focuses on bacterial pathogenicity, oral microbiome, antimicrobial drug resistance, and host-microbe interactions. His work explores how pathogens like Pseudomonas aeruginosa and Streptococcus mutans cause infectious diseases, interact within microbial communities, and develop resistance to antimicrobial agents. He integrates genetics, biochemistry, and multi-omics to investigate virulence systems like Type III and VI secretion, quorum sensing, and biofilm formation. Recent publications highlight trends in targeting Pseudomonas aeruginosa virulence through bitter taste receptor modulation, quorum sensing inhibition, and herbal compounds. His lab specializes in antimicrobial discovery, focusing on host-microbe interactions and cross-kingdom communication in polymicrobial environments. Teaching and Mentorship: Dr. Duan actively mentors graduate students, emphasizing rigorous, discovery-driven research. Ideal candidates possess motivation, logical thinking, and a background in biological sciences. Laboratory: Located at the Bannatyne Campus, Room D35B, the Duan Lab combines molecular microbiology and biotechnology to combat infectious diseases through novel chemical agents and therapeutic strategies.

• Infectious Diseases
• Microbiology
• Immunology
• +۷ مورد دیگر

Damon P. Eisen is a Professor at James Cook University's College of Medicine and Dentistry, specializing in Infectious Diseases and Immunology. His research spans tropical infectious diseases, immunology, and antimicrobial resistance with a particular focus on Staphylococcus aureus infections, biofilm formation, and the role of mannose-binding lectin in immune responses. He has led numerous clinical studies and international collaborations, with significant contributions to understanding sepsis, endocarditis, and tuberculosis. Dr. Eisen's primary research interests center on bacterial pathogenesis, particularly Staphylococcus aureus and its biofilm-related infections in medical devices. His work explores non-antibiotic therapeutic approaches, including repurposed drugs like aspirin and ticagrelor for managing bacterial infections. He has made significant contributions to understanding the role of the complement system, particularly mannose-binding lectin, in infectious disease susceptibility and outcomes. His research also extends to tropical infectious diseases prevalent in Northern Australia, including bacterial meningitis, tuberculosis, and emerging pathogens. Analysis of Dr. Eisen's recent publications reveals a strong focus on translational research bridging basic science and clinical applications. His work consistently addresses antimicrobial resistance challenges through innovative approaches, particularly non-antibiotic adjuvant therapies for biofilm-related infections. The research spans microbiology, immunology, pharmacology, and clinical medicine, with growing emphasis on tropical infectious diseases and their unique epidemiological patterns in Northern Australia. Dr. Eisen has been instrumental in several major clinical trials including the ANTISEPSIS trial examining aspirin's effect on sepsis mortality in older adults. His work has established important clinical guidelines regarding antibiotic timing in bacterial meningitis and contributed significantly to understanding the relationship between respiratory infections and cardiovascular complications. He has led multinational collaborations studying infective endocarditis through the ICE-PCS Investigators consortium. His laboratory and research team focus on bacterial pathogenesis mechanisms, particularly Staphylococcus aureus biofilm formation and strategies to prevent medical device-related infections. The research group employs molecular biology, microbiology, and clinical epidemiology approaches to develop novel therapeutic strategies that could reduce reliance on traditional antibiotics.